Comparative Pharmacology
Head-to-head clinical analysis: HEPTALAC versus SORBITOL 3 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HEPTALAC versus SORBITOL 3 3 IN PLASTIC CONTAINER.
HEPTALAC vs SORBITOL 3.3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ammonia scavenger; lactulose is metabolized by colonic bacteria to organic acids, acidifying the colon, which converts NH3 to NH4+ and promotes ammonia excretion. Lactulose also reduces colonic transit time and bacterial production of ammonia.
Sorbitol is a sugar alcohol that acts as an osmotic diuretic. It increases the osmolarity of the glomerular filtrate, which inhibits renal tubular reabsorption of water and electrolytes, thereby promoting diuresis. Additionally, it reduces intracranial pressure by creating an osmotic gradient that draws water from brain tissue into the cerebrospinal fluid and bloodstream.
Oral: 3.33 g (30 mL) 3 times daily. Rectal: 200 mL of 30% solution as retention enema, 3 times daily. Intravenous: 30 g as a single dose via intra-abdominal instillation.
Intravenous infusion: 100-200 mL of a 3.3% solution (3.3-6.6 g sorbitol) over 15-30 minutes, typically used as an osmotic diuretic or for bowel preparation; frequency depends on indication, e.g., once for diagnostic procedures or up to 4 times daily for bowel evacuation.
None Documented
None Documented
Terminal elimination half-life is 6-12 hours in patients with normal hepatic function; prolonged in hepatic encephalopathy due to altered clearance (up to 24 hours).
1.5–2.5 hours in normal renal function; prolonged in renal impairment (up to 20–30 hours in oliguric states).
Primarily renal (approximately 70-80%) as unchanged drug; minor biliary/fecal elimination (20-30%).
Renal excretion of unchanged sorbitol; >90% eliminated via kidneys within 24 hours. Minor biliary/fecal elimination (<5%).
Category C
Category C
Laxative
Laxative